tradingkey.logo
tradingkey.logo
Search

Stereotaxis Inc

STXS
Add to Watchlist
1.850USD
-0.085-4.38%
Close 05/15, 16:00ETQuotes delayed by 15 min
180.81MMarket Cap
LossP/E TTM

Stereotaxis Inc

1.850
-0.085-4.38%

More Details of Stereotaxis Inc Company

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.

Stereotaxis Inc Info

Ticker SymbolSTXS
Company nameStereotaxis Inc
IPO dateAug 12, 2004
CEOFischel (David Leo)
Number of employees139
Security typeOrdinary Share
Fiscal year-endAug 12
Address710 N Tucker Blvd
CityST. LOUIS
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryUnited States of America
Postal code63101
Phone13146786100
Websitehttps://www.stereotaxis.com/
Ticker SymbolSTXS
IPO dateAug 12, 2004
CEOFischel (David Leo)

Company Executives of Stereotaxis Inc

Name
Name/Position
Position
Shareholding
Change
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
463.30K
-19.56%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
255.00K
+21.57%
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
254.50K
-12.03%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
154.97K
-19.76%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
136.22K
+34.46%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kimberly R. Peery
Ms. Kimberly R. Peery
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
463.30K
-19.56%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
255.00K
+21.57%
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
254.50K
-12.03%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
154.97K
-19.76%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
136.22K
+34.46%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--

Revenue Breakdown

Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
International
19.51M
60.26%
United States
12.87M
39.74%
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Dafna Capital Management, LLC
14.03%
Kiani (Joe E)
10.37%
Lagoda Investment Management, L.P.
4.99%
BlackRock Institutional Trust Company, N.A.
3.82%
2012 Revocable Trust of Andrew Redleaf
3.16%
Other
63.64%
Shareholders
Shareholders
Proportion
Dafna Capital Management, LLC
14.03%
Kiani (Joe E)
10.37%
Lagoda Investment Management, L.P.
4.99%
BlackRock Institutional Trust Company, N.A.
3.82%
2012 Revocable Trust of Andrew Redleaf
3.16%
Other
63.64%
Shareholder Types
Shareholders
Proportion
Investment Advisor
17.49%
Hedge Fund
17.31%
Individual Investor
14.77%
Investment Advisor/Hedge Fund
11.28%
Corporation
3.16%
Bank and Trust
0.65%
Research Firm
0.50%
Pension Fund
0.01%
Other
34.84%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
205
49.70M
50.99%
+2.24M
2025Q4
186
43.95M
47.09%
-1.61M
2025Q3
175
41.68M
45.77%
-4.01M
2025Q2
184
70.71M
77.86%
+13.38M
2025Q1
192
70.55M
82.04%
+9.72M
2024Q4
185
55.40M
64.94%
-4.27M
2024Q3
178
54.77M
64.71%
-4.91M
2024Q2
173
55.07M
66.24%
-4.36M
2024Q1
185
55.40M
67.15%
-4.49M
2023Q4
184
51.49M
64.77%
-9.27M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Dafna Capital Management, LLC
13.68M
14.07%
--
--
Dec 31, 2025
Kiani (Joe E)
8.86M
9.11%
+427.40K
+5.07%
Mar 17, 2025
Lagoda Investment Management, L.P.
4.86M
5%
+153.80K
+3.27%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
3.73M
3.83%
+44.20K
+1.20%
Dec 31, 2025
2012 Revocable Trust of Andrew Redleaf
3.08M
3.16%
--
--
Mar 17, 2025
Arbiter Partners Capital Management, LLC
2.88M
2.97%
+30.00K
+1.05%
Dec 31, 2025
Isaac (Paul J)
2.06M
2.12%
+10.00K
+0.49%
Nov 17, 2025
Essex Investment Management Company, LLC
1.56M
1.61%
-36.09K
-2.26%
Dec 31, 2025
Geode Capital Management, L.L.C.
1.57M
1.61%
+55.49K
+3.68%
Dec 31, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0.03%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
iShares Russell 2000 Value ETF
0%
iShares Russell 2000 ETF
0%
iShares Micro-Cap ETF
Proportion0.03%
Global X Russell 2000 ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
ProShares Hedge Replication ETF
Proportion0.01%
iShares Russell 2000 Growth ETF
Proportion0.01%
iShares Russell 2000 Value ETF
Proportion0%
iShares Russell 2000 ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI